Hidradenitis Suppurativa
📧 Sign up to get email alerts when something new happens for Hidradenitis Suppurativa.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-06-14FDA Approved: ABRILADA — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for ABRILADA (adalimumab-afzb) submitted by Pfizer Laboratories Div Pfizer Inc to update the labelin…
-
CLINICAL_TRIALS trial_result · 2023-06-13Clinical Trial Update: A Study to Evaluate RIST4721 in Hidradenitis Suppurativa (HS) [Phase 2]
Phase 2 trial evaluating RIST4721 in hidradenitis suppurativa was terminated; results posted in 2023.
-
FDA approval · 2023-05-23FDA Approved: ADALIMUMAB — Original Application (CELLTRION USA, Inc.)
FDA approved ADALIMUMAB-AATY from CELLTRION USA, Inc. as a biosimilar to adalimumab under an Original Application for the same indications a…
-
FDA approval · 2023-05-18FDA Approved: ADALIMUMAB-ADBM — Supplemental Application (QUALLENT PHARMACEUTICALS HEALTH LLC)
FDA approved a supplemental application for ADALIMUMAB-ADBM, a biosimilar to adalimumab, from QUALLENT PHARMACEUTICALS HEALTH LLC.
-
CLINICAL_TRIALS trial_result · 2023-04-28Clinical Trial Update: A Study of LY3041658 in Adults With Hidradenitis Suppurativa [Phase 2]
Phase 2 clinical trial of LY3041658 in adults with hidradenitis suppurativa has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-04-14FDA Approved: ADALIMUMAB — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for adalimumab-adaz, a biosimilar to adalimumab, confirming its regulatory approval for use.
-
FDA approval · 2023-03-31FDA Approved: YUSIMRY — Supplemental Application (Coherus BioSciences Inc)
FDA approved a supplemental Biologics License Application for YUSIMRY (adalimumab-aqvh) by Coherus BioSciences, authorizing the biosimilar p…
-
CLINICAL_TRIALS trial_result · 2023-03-14Clinical Trial Update: Wound Dressings for Hidradenitis Suppurativa [NA]
A completed clinical trial investigating wound dressings for hidradenitis suppurativa with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-03-01Clinical Trial Update: Study of the Effect of Fostamatinib Upon Cutaneous Inflammation in the Setting of Hidradenitis Suppurativa [Phase 2]
Phase 2 clinical trial evaluating the effect of fostamatinib on skin inflammation in hidradenitis suppurativa has completed.
-
CLINICAL_TRIALS trial_result · 2023-02-06Clinical Trial Update: A Study of Oral Upadacitinib Tablet Compared to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa to Assess Change in Disease Symptoms [Phase 2]
A Phase 2 trial evaluating oral upadacitinib versus placebo in adults with moderate to severe hidradenitis suppurativa has completed with re…
-
CLINICAL_TRIALS trial_result · 2023-01-26Clinical Trial Update: To Assess the Efficacy and Safety of INCB054707 in Participants With Hidradenitis Suppurativa [Phase 2]
This Phase 2 trial evaluating INCB054707 in hidradenitis suppurativa (acne inversa) completed and results were posted in January 2023.
-
FDA approval · 2022-12-13FDA Approved: IDACIO — Original Application (Fresenius Kabi USA, LLC)
FDA approved IDACIO (adalimumab-afcf) from Fresenius Kabi USA, LLC as a biosimilar to adalimumab (Humira) under an original Biologics Licens…
-
CLINICAL_TRIALS trial_result · 2022-10-26Clinical Trial Update: Trial to Determine the Immunomodulatory Activity of PTM-001 in Patients With Hidradenitis Suppurativa [Phase 2]
Phase 2 trial assessing immunomodulatory activity of PTM-001 in hidradenitis suppurativa.
-
CLINICAL_TRIALS withdrawal · 2022-09-29Clinical Trial Update: Hidradenitis Suppurativa Patient Experience With Humira Treatment [Phase 4]
A Phase 4 clinical trial assessing Humira for hidradenitis suppurativa has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2022-08-11Clinical Trial Update: A Global Study Comparing Risankizumab to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa [Phase 2]
Phase 2 trial comparing risankizumab to placebo in adults with moderate to severe hidradenitis suppurativa completed; results posted in 2022…
-
FDA approval · 2022-07-18FDA Approved: ADALIMUMAB — Supplemental Application (Sandoz Inc)
The FDA approved Sandoz's supplemental application for the adalimumab biosimilar ADALIMUMAB-ADAZ. The approval covers multiple inflammatory …
-
CLINICAL_TRIALS trial_result · 2022-04-06Clinical Trial Update: Evaluating the Effect of a Written Action Plan on Comfort and Understanding of Hidradenitis Suppurativa [NA]
Completed clinical trial evaluating a written action plan for comfort and understanding in hidradenitis suppurativa; results posted.
-
CLINICAL_TRIALS trial_result · 2022-03-14Clinical Trial Update: A Study of Bermekimab in Patients With Hidradenitis Suppurativa [Phase 2]
Phase 2 trial update for bermekimab in hidradenitis suppurativa has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-02-09Clinical Trial Update: A Study to Test the Efficacy, Safety and Pharmacokinetics of Bimekizumab in Subjects With Moderate to Severe Hidradenitis Suppurativa. [Phase 2]
Phase 2 clinical trial evaluating the efficacy, safety, and pharmacokinetics of bimekizumab in moderate to severe hidradenitis suppurativa h…
-
FDA approval · 2021-12-17FDA Approved: YUSIMRY — Original Application (Coherus BioSciences Inc)
FDA approved YUSIMRY (adalimumab-aqvh) from Coherus BioSciences in an original biologics license application, likely as a biosimilar to adal…
-
CLINICAL_TRIALS trial_result · 2021-10-20Clinical Trial Update: Low Dose Radiotherapy for Advanced Hidradenitis Suppurativa [NA]
Clinical trial update for low dose radiotherapy in advanced hidradenitis suppurativa has been terminated; results posted in 2021.
-
FDA approval · 2021-10-15FDA Approved: ADALIMUMAB-ADBM — Supplemental Application (QUALLENT PHARMACEUTICALS HEALTH LLC)
FDA approves a supplemental application for the adalimumab biosimilar ADALIMUMAB-ADBM from Quallent Pharmaceuticals Health LLC. The approval…
-
CLINICAL_TRIALS trial_result · 2021-09-28Clinical Trial Update: Orismilast for the Treatment of Mild to Severe Hidradenitis Suppurativa [Phase 2]
Phase 2 trial update for orismilast in mild to severe hidradenitis suppurativa.
-
CLINICAL_TRIALS trial_result · 2021-08-30Clinical Trial Update: LTX-109 as Treatment for Hidradenitis Suppurativa [Phase 1, Phase 2]
Phase 1/2 clinical trial update for LTX-109 in hidradenitis suppurativa has completed.
-
CLINICAL_TRIALS trial_result · 2021-06-14Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Tolerability of Guselkumab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa (HS) [Phase 2]
A Phase 2 clinical trial evaluating the efficacy, safety, and tolerability of guselkumab for moderate-to-severe hidradenitis suppurativa com…